1 Study Coverage
1.1 Enzalutamide API Product Introduction
1.2 Market by Type
1.2.1 Global Enzalutamide API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity=98%
1.2.3 Purity<98%
1.3 Market by Application
1.3.1 Global Enzalutamide API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Enzalutamide Capsules
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Enzalutamide API Production
2.1 Global Enzalutamide API Production Capacity (2017-2028)
2.2 Global Enzalutamide API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Enzalutamide API Production by Region
2.3.1 Global Enzalutamide API Historic Production by Region (2017-2022)
2.3.2 Global Enzalutamide API Forecasted Production by Region (2023-2028)
2.4 Europe
2.5 China
2.6 China Taiwan
2.7 India
3 Global Enzalutamide API Sales in Volume & Value Estimates and Forecasts
3.1 Global Enzalutamide API Sales Estimates and Forecasts 2017-2028
3.2 Global Enzalutamide API Revenue Estimates and Forecasts 2017-2028
3.3 Global Enzalutamide API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Enzalutamide API Sales by Region
3.4.1 Global Enzalutamide API Sales by Region (2017-2022)
3.4.2 Global Sales Enzalutamide API by Region (2023-2028)
3.5 Global Enzalutamide API Revenue by Region
3.5.1 Global Enzalutamide API Revenue by Region (2017-2022)
3.5.2 Global Enzalutamide API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Enzalutamide API Production Capacity by Manufacturers
4.2 Global Enzalutamide API Sales by Manufacturers
4.2.1 Global Enzalutamide API Sales by Manufacturers (2017-2022)
4.2.2 Global Enzalutamide API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Enzalutamide API in 2021
4.3 Global Enzalutamide API Revenue by Manufacturers
4.3.1 Global Enzalutamide API Revenue by Manufacturers (2017-2022)
4.3.2 Global Enzalutamide API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Enzalutamide API Revenue in 2021
4.4 Global Enzalutamide API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Enzalutamide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Enzalutamide API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Enzalutamide API Sales by Type
5.1.1 Global Enzalutamide API Historical Sales by Type (2017-2022)
5.1.2 Global Enzalutamide API Forecasted Sales by Type (2023-2028)
5.1.3 Global Enzalutamide API Sales Market Share by Type (2017-2028)
5.2 Global Enzalutamide API Revenue by Type
5.2.1 Global Enzalutamide API Historical Revenue by Type (2017-2022)
5.2.2 Global Enzalutamide API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Enzalutamide API Revenue Market Share by Type (2017-2028)
5.3 Global Enzalutamide API Price by Type
5.3.1 Global Enzalutamide API Price by Type (2017-2022)
5.3.2 Global Enzalutamide API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Enzalutamide API Sales by Application
6.1.1 Global Enzalutamide API Historical Sales by Application (2017-2022)
6.1.2 Global Enzalutamide API Forecasted Sales by Application (2023-2028)
6.1.3 Global Enzalutamide API Sales Market Share by Application (2017-2028)
6.2 Global Enzalutamide API Revenue by Application
6.2.1 Global Enzalutamide API Historical Revenue by Application (2017-2022)
6.2.2 Global Enzalutamide API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Enzalutamide API Revenue Market Share by Application (2017-2028)
6.3 Global Enzalutamide API Price by Application
6.3.1 Global Enzalutamide API Price by Application (2017-2022)
6.3.2 Global Enzalutamide API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Enzalutamide API Market Size by Type
7.1.1 North America Enzalutamide API Sales by Type (2017-2028)
7.1.2 North America Enzalutamide API Revenue by Type (2017-2028)
7.2 North America Enzalutamide API Market Size by Application
7.2.1 North America Enzalutamide API Sales by Application (2017-2028)
7.2.2 North America Enzalutamide API Revenue by Application (2017-2028)
7.3 North America Enzalutamide API Sales by Country
7.3.1 North America Enzalutamide API Sales by Country (2017-2028)
7.3.2 North America Enzalutamide API Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Enzalutamide API Market Size by Type
8.1.1 Europe Enzalutamide API Sales by Type (2017-2028)
8.1.2 Europe Enzalutamide API Revenue by Type (2017-2028)
8.2 Europe Enzalutamide API Market Size by Application
8.2.1 Europe Enzalutamide API Sales by Application (2017-2028)
8.2.2 Europe Enzalutamide API Revenue by Application (2017-2028)
8.3 Europe Enzalutamide API Sales by Country
8.3.1 Europe Enzalutamide API Sales by Country (2017-2028)
8.3.2 Europe Enzalutamide API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Enzalutamide API Market Size by Type
9.1.1 Asia Pacific Enzalutamide API Sales by Type (2017-2028)
9.1.2 Asia Pacific Enzalutamide API Revenue by Type (2017-2028)
9.2 Asia Pacific Enzalutamide API Market Size by Application
9.2.1 Asia Pacific Enzalutamide API Sales by Application (2017-2028)
9.2.2 Asia Pacific Enzalutamide API Revenue by Application (2017-2028)
9.3 Asia Pacific Enzalutamide API Sales by Region
9.3.1 Asia Pacific Enzalutamide API Sales by Region (2017-2028)
9.3.2 Asia Pacific Enzalutamide API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Enzalutamide API Market Size by Type
10.1.1 Latin America Enzalutamide API Sales by Type (2017-2028)
10.1.2 Latin America Enzalutamide API Revenue by Type (2017-2028)
10.2 Latin America Enzalutamide API Market Size by Application
10.2.1 Latin America Enzalutamide API Sales by Application (2017-2028)
10.2.2 Latin America Enzalutamide API Revenue by Application (2017-2028)
10.3 Latin America Enzalutamide API Sales by Country
10.3.1 Latin America Enzalutamide API Sales by Country (2017-2028)
10.3.2 Latin America Enzalutamide API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Enzalutamide API Market Size by Type
11.1.1 Middle East and Africa Enzalutamide API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Enzalutamide API Revenue by Type (2017-2028)
11.2 Middle East and Africa Enzalutamide API Market Size by Application
11.2.1 Middle East and Africa Enzalutamide API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Enzalutamide API Revenue by Application (2017-2028)
11.3 Middle East and Africa Enzalutamide API Sales by Country
11.3.1 Middle East and Africa Enzalutamide API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Enzalutamide API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Dr. Reddy’s Laboratories Ltd.
12.1.1 Dr. Reddy’s Laboratories Ltd. Corporation Information
12.1.2 Dr. Reddy’s Laboratories Ltd. Overview
12.1.3 Dr. Reddy’s Laboratories Ltd. Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Dr. Reddy’s Laboratories Ltd. Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments
12.2 Shilpa Medicare Limited
12.2.1 Shilpa Medicare Limited Corporation Information
12.2.2 Shilpa Medicare Limited Overview
12.2.3 Shilpa Medicare Limited Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Shilpa Medicare Limited Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Shilpa Medicare Limited Recent Developments
12.3 ScinoPharm Taiwan, Ltd
12.3.1 ScinoPharm Taiwan, Ltd Corporation Information
12.3.2 ScinoPharm Taiwan, Ltd Overview
12.3.3 ScinoPharm Taiwan, Ltd Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 ScinoPharm Taiwan, Ltd Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 ScinoPharm Taiwan, Ltd Recent Developments
12.4 Olon Spa
12.4.1 Olon Spa Corporation Information
12.4.2 Olon Spa Overview
12.4.3 Olon Spa Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Olon Spa Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Olon Spa Recent Developments
12.5 Farmhispania, S.A.
12.5.1 Farmhispania, S.A. Corporation Information
12.5.2 Farmhispania, S.A. Overview
12.5.3 Farmhispania, S.A. Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Farmhispania, S.A. Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Farmhispania, S.A. Recent Developments
12.6 Mac-Chem Products (India) Pvt.Ltd
12.6.1 Mac-Chem Products (India) Pvt.Ltd Corporation Information
12.6.2 Mac-Chem Products (India) Pvt.Ltd Overview
12.6.3 Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments
12.7 Shandong Haohong Biotechnology
12.7.1 Shandong Haohong Biotechnology Corporation Information
12.7.2 Shandong Haohong Biotechnology Overview
12.7.3 Shandong Haohong Biotechnology Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Shandong Haohong Biotechnology Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Shandong Haohong Biotechnology Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Enzalutamide API Industry Chain Analysis
13.2 Enzalutamide API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Enzalutamide API Production Mode & Process
13.4 Enzalutamide API Sales and Marketing
13.4.1 Enzalutamide API Sales Channels
13.4.2 Enzalutamide API Distributors
13.5 Enzalutamide API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Enzalutamide API Industry Trends
14.2 Enzalutamide API Market Drivers
14.3 Enzalutamide API Market Challenges
14.4 Enzalutamide API Market Restraints
15 Key Finding in The Global Enzalutamide API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Enzalutamide API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity=98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Enzalutamide API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Enzalutamide API Production by Region: 2017 VS 2021 VS 2028 (Kiloton)
Table 6. Global Enzalutamide API Production by Region (2017-2022) & (Kiloton)
Table 7. Global Enzalutamide API Production Market Share by Region (2017-2022)
Table 8. Global Enzalutamide API Production by Region (2023-2028) & (Kiloton)
Table 9. Global Enzalutamide API Production Market Share by Region (2023-2028)
Table 10. Global Enzalutamide API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Enzalutamide API Sales by Region (2017-2022) & (Kiloton)
Table 12. Global Enzalutamide API Sales Market Share by Region (2017-2022)
Table 13. Global Enzalutamide API Sales by Region (2023-2028) & (Kiloton)
Table 14. Global Enzalutamide API Sales Market Share by Region (2023-2028)
Table 15. Global Enzalutamide API Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Enzalutamide API Revenue Market Share by Region (2017-2022)
Table 17. Global Enzalutamide API Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Enzalutamide API Revenue Market Share by Region (2023-2028)
Table 19. Global Enzalutamide API Production Capacity by Manufacturers (2017-2022) & (Kiloton)
Table 20. Global Enzalutamide API Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Enzalutamide API Sales by Manufacturers (2017-2022) & (Kiloton)
Table 22. Global Enzalutamide API Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Enzalutamide API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Enzalutamide API Revenue Share by Manufacturers (2017-2022)
Table 25. Enzalutamide API Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Enzalutamide API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Enzalutamide API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzalutamide API as of 2021)
Table 28. Enzalutamide API Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Enzalutamide API Product Offered
Table 30. Date of Manufacturers Enter into Enzalutamide API Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Enzalutamide API Sales by Type (2017-2022) & (Kiloton)
Table 33. Global Enzalutamide API Sales by Type (2023-2028) & (Kiloton)
Table 34. Global Enzalutamide API Sales Share by Type (2017-2022)
Table 35. Global Enzalutamide API Sales Share by Type (2023-2028)
Table 36. Global Enzalutamide API Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Enzalutamide API Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Enzalutamide API Revenue Share by Type (2017-2022)
Table 39. Global Enzalutamide API Revenue Share by Type (2023-2028)
Table 40. Enzalutamide API Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Enzalutamide API Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Enzalutamide API Sales by Application (2017-2022) & (Kiloton)
Table 43. Global Enzalutamide API Sales by Application (2023-2028) & (Kiloton)
Table 44. Global Enzalutamide API Sales Share by Application (2017-2022)
Table 45. Global Enzalutamide API Sales Share by Application (2023-2028)
Table 46. Global Enzalutamide API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Enzalutamide API Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Enzalutamide API Revenue Share by Application (2017-2022)
Table 49. Global Enzalutamide API Revenue Share by Application (2023-2028)
Table 50. Enzalutamide API Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Enzalutamide API Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Enzalutamide API Sales by Type (2017-2022) & (Kiloton)
Table 53. North America Enzalutamide API Sales by Type (2023-2028) & (Kiloton)
Table 54. North America Enzalutamide API Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Enzalutamide API Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Enzalutamide API Sales by Application (2017-2022) & (Kiloton)
Table 57. North America Enzalutamide API Sales by Application (2023-2028) & (Kiloton)
Table 58. North America Enzalutamide API Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Enzalutamide API Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Enzalutamide API Sales by Country (2017-2022) & (Kiloton)
Table 61. North America Enzalutamide API Sales by Country (2023-2028) & (Kiloton)
Table 62. North America Enzalutamide API Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Enzalutamide API Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Enzalutamide API Sales by Type (2017-2022) & (Kiloton)
Table 65. Europe Enzalutamide API Sales by Type (2023-2028) & (Kiloton)
Table 66. Europe Enzalutamide API Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Enzalutamide API Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Enzalutamide API Sales by Application (2017-2022) & (Kiloton)
Table 69. Europe Enzalutamide API Sales by Application (2023-2028) & (Kiloton)
Table 70. Europe Enzalutamide API Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Enzalutamide API Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Enzalutamide API Sales by Country (2017-2022) & (Kiloton)
Table 73. Europe Enzalutamide API Sales by Country (2023-2028) & (Kiloton)
Table 74. Europe Enzalutamide API Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Enzalutamide API Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Enzalutamide API Sales by Type (2017-2022) & (Kiloton)
Table 77. Asia Pacific Enzalutamide API Sales by Type (2023-2028) & (Kiloton)
Table 78. Asia Pacific Enzalutamide API Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Enzalutamide API Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Enzalutamide API Sales by Application (2017-2022) & (Kiloton)
Table 81. Asia Pacific Enzalutamide API Sales by Application (2023-2028) & (Kiloton)
Table 82. Asia Pacific Enzalutamide API Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Enzalutamide API Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Enzalutamide API Sales by Region (2017-2022) & (Kiloton)
Table 85. Asia Pacific Enzalutamide API Sales by Region (2023-2028) & (Kiloton)
Table 86. Asia Pacific Enzalutamide API Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Enzalutamide API Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Enzalutamide API Sales by Type (2017-2022) & (Kiloton)
Table 89. Latin America Enzalutamide API Sales by Type (2023-2028) & (Kiloton)
Table 90. Latin America Enzalutamide API Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Enzalutamide API Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Enzalutamide API Sales by Application (2017-2022) & (Kiloton)
Table 93. Latin America Enzalutamide API Sales by Application (2023-2028) & (Kiloton)
Table 94. Latin America Enzalutamide API Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Enzalutamide API Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Enzalutamide API Sales by Country (2017-2022) & (Kiloton)
Table 97. Latin America Enzalutamide API Sales by Country (2023-2028) & (Kiloton)
Table 98. Latin America Enzalutamide API Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Enzalutamide API Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Enzalutamide API Sales by Type (2017-2022) & (Kiloton)
Table 101. Middle East and Africa Enzalutamide API Sales by Type (2023-2028) & (Kiloton)
Table 102. Middle East and Africa Enzalutamide API Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Enzalutamide API Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Enzalutamide API Sales by Application (2017-2022) & (Kiloton)
Table 105. Middle East and Africa Enzalutamide API Sales by Application (2023-2028) & (Kiloton)
Table 106. Middle East and Africa Enzalutamide API Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Enzalutamide API Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Enzalutamide API Sales by Country (2017-2022) & (Kiloton)
Table 109. Middle East and Africa Enzalutamide API Sales by Country (2023-2028) & (Kiloton)
Table 110. Middle East and Africa Enzalutamide API Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Enzalutamide API Revenue by Country (2023-2028) & (US$ Million)
Table 112. Dr. Reddy’s Laboratories Ltd. Corporation Information
Table 113. Dr. Reddy’s Laboratories Ltd. Description and Major Businesses
Table 114. Dr. Reddy’s Laboratories Ltd. Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Dr. Reddy’s Laboratories Ltd. Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 117. Shilpa Medicare Limited Corporation Information
Table 118. Shilpa Medicare Limited Description and Major Businesses
Table 119. Shilpa Medicare Limited Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Shilpa Medicare Limited Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Shilpa Medicare Limited Recent Development
Table 122. ScinoPharm Taiwan, Ltd Corporation Information
Table 123. ScinoPharm Taiwan, Ltd Description and Major Businesses
Table 124. ScinoPharm Taiwan, Ltd Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. ScinoPharm Taiwan, Ltd Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. ScinoPharm Taiwan, Ltd Recent Development
Table 127. Olon Spa Corporation Information
Table 128. Olon Spa Description and Major Businesses
Table 129. Olon Spa Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Olon Spa Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Olon Spa Recent Development
Table 132. Farmhispania, S.A. Corporation Information
Table 133. Farmhispania, S.A. Description and Major Businesses
Table 134. Farmhispania, S.A. Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Farmhispania, S.A. Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Farmhispania, S.A. Recent Development
Table 137. Mac-Chem Products (India) Pvt.Ltd Corporation Information
Table 138. Mac-Chem Products (India) Pvt.Ltd Description and Major Businesses
Table 139. Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Mac-Chem Products (India) Pvt.Ltd Recent Development
Table 142. Shandong Haohong Biotechnology Corporation Information
Table 143. Shandong Haohong Biotechnology Description and Major Businesses
Table 144. Shandong Haohong Biotechnology Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 145. Shandong Haohong Biotechnology Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Shandong Haohong Biotechnology Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Enzalutamide API Distributors List
Table 150. Enzalutamide API Customers List
Table 151. Enzalutamide API Market Trends
Table 152. Enzalutamide API Market Drivers
Table 153. Enzalutamide API Market Challenges
Table 154. Enzalutamide API Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Enzalutamide API Product Picture
Figure 2. Global Enzalutamide API Market Share by Type in 2021 & 2028
Figure 3. Purity=98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Enzalutamide API Market Share by Application in 2021 & 2028
Figure 6. Enzalutamide Capsules
Figure 7. Others
Figure 8. Enzalutamide API Report Years Considered
Figure 9. Global Enzalutamide API Capacity, Production and Utilization (2017-2028) & (Kiloton)
Figure 10. Global Enzalutamide API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 11. Global Enzalutamide API Production Market Share by Region (2017-2022)
Figure 12. Global Enzalutamide API Production Market Share by Region (2023-2028)
Figure 13. Enzalutamide API Production Growth Rate in Europe (2017-2028) & (Kiloton)
Figure 14. Enzalutamide API Production Growth Rate in China (2017-2028) & (Kiloton)
Figure 15. Enzalutamide API Production Growth Rate in China Taiwan (2017-2028) & (Kiloton)
Figure 16. Enzalutamide API Production Growth Rate in India (2017-2028) & (Kiloton)
Figure 17. Global Enzalutamide API Sales 2017-2028 (Kiloton)
Figure 18. Global Enzalutamide API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Enzalutamide API Revenue 2017-2028 (US$ Million)
Figure 20. Global Enzalutamide API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Enzalutamide API Sales Market Share by Region (2017-2022)
Figure 22. Global Enzalutamide API Sales Market Share by Region (2023-2028)
Figure 23. North America Enzalutamide API Sales YoY (2017-2028) & (Kiloton)
Figure 24. North America Enzalutamide API Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Enzalutamide API Sales YoY (2017-2028) & (Kiloton)
Figure 26. Europe Enzalutamide API Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Enzalutamide API Sales YoY (2017-2028) & (Kiloton)
Figure 28. Asia-Pacific Enzalutamide API Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Enzalutamide API Sales YoY (2017-2028) & (Kiloton)
Figure 30. Latin America Enzalutamide API Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Enzalutamide API Sales YoY (2017-2028) & (Kiloton)
Figure 32. Middle East & Africa Enzalutamide API Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Enzalutamide API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Enzalutamide API in the World: Market Share by Enzalutamide API Revenue in 2021
Figure 35. Enzalutamide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Enzalutamide API Sales Market Share by Type (2017-2028)
Figure 37. Global Enzalutamide API Revenue Market Share by Type (2017-2028)
Figure 38. Global Enzalutamide API Sales Market Share by Application (2017-2028)
Figure 39. Global Enzalutamide API Revenue Market Share by Application (2017-2028)
Figure 40. North America Enzalutamide API Sales Market Share by Type (2017-2028)
Figure 41. North America Enzalutamide API Revenue Market Share by Type (2017-2028)
Figure 42. North America Enzalutamide API Sales Market Share by Application (2017-2028)
Figure 43. North America Enzalutamide API Revenue Market Share by Application (2017-2028)
Figure 44. North America Enzalutamide API Sales Share by Country (2017-2028)
Figure 45. North America Enzalutamide API Revenue Share by Country (2017-2028)
Figure 46. U.S. Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Enzalutamide API Sales Market Share by Type (2017-2028)
Figure 49. Europe Enzalutamide API Revenue Market Share by Type (2017-2028)
Figure 50. Europe Enzalutamide API Sales Market Share by Application (2017-2028)
Figure 51. Europe Enzalutamide API Revenue Market Share by Application (2017-2028)
Figure 52. Europe Enzalutamide API Sales Share by Country (2017-2028)
Figure 53. Europe Enzalutamide API Revenue Share by Country (2017-2028)
Figure 54. Germany Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 55. France Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Enzalutamide API Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific Enzalutamide API Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific Enzalutamide API Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Enzalutamide API Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Enzalutamide API Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Enzalutamide API Revenue Share by Region (2017-2028)
Figure 65. China Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 68. India Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 70. Taiwan Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 74. Philippines Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America Enzalutamide API Sales Market Share by Type (2017-2028)
Figure 76. Latin America Enzalutamide API Revenue Market Share by Type (2017-2028)
Figure 77. Latin America Enzalutamide API Sales Market Share by Application (2017-2028)
Figure 78. Latin America Enzalutamide API Revenue Market Share by Application (2017-2028)
Figure 79. Latin America Enzalutamide API Sales Share by Country (2017-2028)
Figure 80. Latin America Enzalutamide API Revenue Share by Country (2017-2028)
Figure 81. Mexico Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa Enzalutamide API Sales Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Enzalutamide API Revenue Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Enzalutamide API Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Enzalutamide API Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Enzalutamide API Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa Enzalutamide API Revenue Share by Country (2017-2028)
Figure 90. Turkey Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 92. U.A.E Enzalutamide API Revenue (2017-2028) & (US$ Million)
Figure 93. Enzalutamide API Value Chain
Figure 94. Enzalutamide API Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
